Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699413 · ClinicalTrials.gov registry record · Phase 4
Supplements for Controlling Resistance to Insulin
A Phase 4 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT00699413 is a Phase 4 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 8 participants.
The verdict
NCT00699413, a Phase 4 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.
Interventions
- DRUG nutrition education plus active supplement
- DRUG nutrition education plus inactive supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00699413
The ClinicalTrials.gov registry entry for NCT00699413 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nutrition education plus active supplement is the first listed.
NCT00699413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00699413 about?
NCT00699413 is a clinical study titled "Supplements for Controlling Resistance to Insulin". The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participants will be evaluated with regard to BMI, percent body fat, insulin activity, and hunger.
What is the current status of trial NCT00699413?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2008-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00699413?
The interventions under investigation include: nutrition education plus active supplement (DRUG), nutrition education plus inactive supplement (DRUG).
Who is sponsoring clinical trial NCT00699413?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.